Rougeot C, Tiberghein C, Minary P, Dray F
INSERM U207, Institut Pasteur, URIA, Paris, France.
J Lipid Mediat. 1991 Jul-Aug;4(1):45-59.
We have previously shown that exogenous (1 to 5 nmol i.c.v.) PAF induces a rapid increase in plasma ACTH and beta endorphin followed by an increase in plasma corticosterone in conscious rats. The stimulatory action of PAF on the secretion of hypothalamic-pituitary-adrenal (HPA) axis products is mediated at least partly by stimulating hypothalamic CRF release. In addition rat hypothalamic membranes have two populations of specific PAF binding sites. In order to clarify the mode of PAF action on the stress-related hormones, we have now investigated the effect of two PAF antagonists, BN 50739 and RP 52770, on basal and PAF-induced ACTH and corticosterone secretion by conscious rats and on PAF specific binding to rat hypothalamic membranes. The role of PAF as a mediator of neuroendocrine secretion in response to acute stress was examined by determining the effect of PAF antagonists on ether-stress inducing HPA activity. We have also investigated their effect on IL 1-induced HPA activity. The ability of BN 50739 and RP 52770 to displace 3H PAF from its hypothalamic binding sites was correlated with their ability to alter basal hormone secretion and to counteract the PAF-stimulated secretion of HPA axis hormones in vivo (P less than 0.05 by ANOVA). Pretreatment with BN 50739. (50 nmol i.c.v.) did not alter ACTH response to a 1 min ether exposure or to IL1 beta injection (2 nmol i.c.v.). In contrast, RP 52770 (55 nmol i.c.v.) significantly inhibited the ether stress-induced ACTH and corticosterone production by 50% (P less than 0.05). In parallel, pretreatment with RP 52770 (55 nmol i.c.v.) caused a significant inhibition of IL1 beta-induced ACTH secretion. These results suggest that PAF acts, in vivo, on ACTH and corticosterone secretion, through a centrally mediated CRF dependent mechanism involving PAF receptor sites. Additionally, the data also indicate that PAF could have a central role in mediating basal and stress-induced ACTH secretion and that IL 1-induced HPA secretion may be mediated at least in part through the production of PAF.
我们之前已经表明,外源性(脑室内注射1至5纳摩尔)血小板活化因子(PAF)可使清醒大鼠血浆促肾上腺皮质激素(ACTH)和β-内啡肽迅速增加,随后血浆皮质酮增加。PAF对下丘脑-垂体-肾上腺(HPA)轴产物分泌的刺激作用至少部分是通过刺激下丘脑促肾上腺皮质激素释放因子(CRF)释放来介导的。此外,大鼠下丘脑膜有两类特异性PAF结合位点。为了阐明PAF对应激相关激素的作用方式,我们现在研究了两种PAF拮抗剂BN 50739和RP 52770对清醒大鼠基础及PAF诱导的ACTH和皮质酮分泌的影响,以及对PAF与大鼠下丘脑膜特异性结合的影响。通过测定PAF拮抗剂对乙醚应激诱导的HPA活性的影响,研究了PAF作为神经内分泌分泌介质在急性应激反应中的作用。我们还研究了它们对白细胞介素1(IL-1)诱导的HPA活性的影响。BN 50739和RP 52770从下丘脑结合位点置换3H-PAF的能力与其改变基础激素分泌以及在体内对抗PAF刺激下HPA轴激素分泌的能力相关(方差分析,P<0.05)。脑室内注射50纳摩尔BN 50739预处理,不改变ACTH对1分钟乙醚暴露或白细胞介素1β(脑室内注射2纳摩尔)注射的反应。相反,脑室内注射55纳摩尔RP 52770可使乙醚应激诱导的ACTH和皮质酮产生显著抑制50%(P<0.05)。同时,脑室内注射55纳摩尔RP 52770预处理可显著抑制白细胞介素1β诱导的ACTH分泌。这些结果表明,PAF在体内通过涉及PAF受体位点的中枢介导的CRF依赖性机制作用于ACTH和皮质酮分泌。此外,数据还表明,PAF可能在介导基础和应激诱导的ACTH分泌中起核心作用,并且IL-1诱导的HPA分泌可能至少部分通过PAF的产生来介导。